Clinical implications of lamivudine resistance by HBV

Additional Metadata
Persistent URL	doi.org/10.1016/S0140-6736(05)62154-X, hdl.handle.net/1765/52041
Journal	The Lancet
Organisation	Department of Internal Medicine
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Schalm, S. (1997). Clinical implications of lamivudine resistance by HBV. The Lancet, 349(9044), 3–4. doi:10.1016/S0140-6736(05)62154-X

Publication